The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...
2hon MSN
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...
Proactively managing atrial fibrillation is crucial for patients and healthcare providers, often necessitating the use of drugs due to the condition's propensity for severe consequences ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...
Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue ...
Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback